VNDA Competitors & Alternatives
Compare Vanda Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
VNDA
Main Stock$5.10
Tradestie Score
42
Market Cap
$301.35M
Revenue Growth
0.0%
Analyst Upside
+177.0%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$40.08
|
$353.70M | - | 54 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.84
|
$341.56M | - | 47 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.10
|
$332.96M | - | 51 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.49
|
$308.74M | - | 54 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.01
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$19.75
|
$297.23M | - | 52 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$28.03
|
$293.03M | - | 51 | Compare |
|
OMER
Omeros Corporation
|
$11.84
|
$281.75M | 10.2 | 56 | Compare |
|
DBVT
DBV Technologies S.A.
|
$13.50
|
$275.54M | - | 41 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.88
|
$275.13M | - | 50 | Compare |
More VNDA Analysis
Data updated: Aug 02, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry